Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSE: Zoledronic Acid vs Alendronate in Postmenopausal Osteoporosis
NCT00404820Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in osteoporosis, osteopenia, sponsored by Novartis. Started Oct 2006; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on NCT00404820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404820.